Ory Daniel Scott reported EDIT

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002149618-26-000006

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 8, 2026

Published

Sep 9, 2026

Ingested by INSIDER

Nov 5, 02:18 UTC

Last re-read

Nov 5, 02:18 UTC

Extracted facts

Filer

Ory Daniel Scott

Role

EVP, Chief Medical Officer

Transaction

Grant or awardAs filed: “A”

Asset

Editas Medicine, Inc. — Stock Option (right to buy)

Ticker

EDIT

Shares

950.0K

Price per share

$0

Execution date (reported)

Sep 8, 2026

Owned after transaction

950.0K shares

Days from execution to publication

1

What this establishes

Ory Daniel Scott filed this Form 4 reporting a grant or award of EDIT on Sep 8, 2026. It became public on Sep 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

EVP, Chief Medical Officer

Ory Daniel Scottcik:0002149618

Issuer

Editas Medicine, Inc.cik:0001650664

Revision history · 0

No field has changed since this record was first ingested.